Eversept Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
1,315,033
+498,779
| +61% | +$7.38M | 1.79% | 16 |
|
|
2025
Q1 | $14.6M | Buy |
816,254
+325,958
| +66% | +$5.84M | 1.49% | 23 |
|
|
2024
Q4 | $8.54M | Sell |
490,296
-379,617
| -44% | -$6.61M | 0.76% | 24 |
|
|
2024
Q3 | $12.2M | Sell |
869,913
-221,252
| -20% | -$3.1M | 0.83% | 23 |
|
|
2024
Q2 | $8.97M | Buy |
1,091,165
+135,547
| +14% | +$1.11M | 0.61% | 28 |
|
|
2024
Q1 | $7.37M | Buy |
+955,618
| New | +$7.37M | 0.49% | 36 |
|